{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:40Z","timestamp":1786120360113,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"DOI":"10.1097\/qai.0b013e31824d2134","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T02:30:30Z","timestamp":1328927430000},"page":"51-58","source":"Crossref","is-referenced-by-count":10,"title":["Biomarkers to Monitor Safety in People on ART and Risk of Mortality"],"prefix":"10.1097","volume":"60","author":[{"given":"Loveleen","family":"Bansi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gazzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Leen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":". Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-8-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2005.00271.x","article-title":"Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.","volume":"6","author":"Krentz","year":"2005","journal-title":"HIV Med"},{"key":"R4-8-20210131","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":". Combination antiretroviral therapy and the risk of myocardial infarction.","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-8-20210131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1293.2007.00434.x","article-title":". Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretrovial therapy era: relationships with gender.","volume":"8","author":"Shah","year":"2007","journal-title":"HIV Med"},{"key":"R6-8-20210131","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(02)11519-4","article-title":". Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.","volume":"360","author":"Sabin","year":"2002","journal-title":"Lancet"},{"key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(89)92042-4","article-title":"Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes.","volume":"2","author":"Phillips","year":"1989","journal-title":"Lancet"},{"key":"R8-8-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1468-1293.2004.00197.x","article-title":"The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study.","volume":"5","year":"2004","journal-title":"HIV Med"},{"key":"R10-8-20210131","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/135965350701200808","article-title":". Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification.","volume":"12","author":"Keiser","year":"2007","journal-title":"Antivir Ther"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/j.1572-0241.2005.41822.x","article-title":". Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern.","volume":"100","author":"Elinav","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R13-8-20210131","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/317449","article-title":". and Prometheus Study Group. Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study Group.","volume":"31","author":"Gisolf","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R14-8-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":". Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"key":"R15-8-20210131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00002030-200201250-00020","article-title":". Liver toxicity caused by nevirapine.","volume":"16","author":"Requena","year":"2002","journal-title":"AIDS"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32833c3281","article-title":". Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.","volume":"24","author":"Welz","year":"2010","journal-title":"AIDS"},{"key":"R17-8-20210131","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/135965350801300803","article-title":". Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.","volume":"13","author":"Fux","year":"2008","journal-title":"Antivir Ther"},{"key":"R18-8-20210131","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.1989.03430170067030","article-title":". Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.","volume":"262","author":"Fischl","year":"1989","journal-title":"JAMA"},{"key":"R19-8-20210131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/520150","article-title":"Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.","volume":"29","author":"Simpson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R20-8-20210131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00062752-199903000-00006","article-title":"Pathogenesis and pathophysiology of anemia in HIV infection.","volume":"6","author":"Bain","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"R21-8-20210131","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-1293.2007.00500.x","article-title":". Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.","volume":"8","author":"Curkendall","year":"2007","journal-title":"HIV Med"},{"key":"R22-8-20210131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V91.1.301","article-title":". Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project.","volume":"91","author":"Sullivan","year":"1998","journal-title":"Blood"},{"key":"R23-8-20210131","first-page":"5","article-title":". Effect of antiviral drugs and hematopoietic growth factors on in vitro erythropoiesis.","volume":"65","author":"Weinberg","year":"1998","journal-title":"Mt Sinai J Med"},{"key":"R24-8-20210131","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1001\/jama.1988.03410200065027","article-title":". Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.","volume":"260","author":"Creagh-Kirk","year":"1988","journal-title":"JAMA"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201205010-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:37:19Z","timestamp":1786048639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201205010-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31824d2134","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}